Breaking News

Webster Equity Partners Acquires Manufacturing Business from Corium and Gurnet Point Capital

Corium separates into two companies: Corium Pharma Solutions and Corium.

Author Image

By: Charlie Sternberg

Associate Editor

Corium LLC, a commercial-stage biopharmaceutical company, and Gurnet Point Capital, a private investment firm focused on the healthcare and life sciences sectors, have announced the acquisition of their manufacturing business and a $100 million equity investment by Webster Equity Partners, a healthcare-focused private equity firm.   The manufacturing business, named Corium Pharma Solutions Inc., transacted with an investment by Webster for more than $400 million in value. A significant Mil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters